Conferences - Results from #100

ASCO GU 2021: Discussant: Results from the TRISST and SEMS Trials February 17, 2021

ASCO GU 2021: Bench to Bedside: Critical Pathways in Renal Cell Carcinoma – Radiology “Write This Down” - What Do Nonradiologists Need to Know February 17, 2021

ASCO GU 2021: Bench to Bedside: Critical Pathways in Renal Cell Carcinoma – Quality of Life Corner February 17, 2021

ASCO GU 2021: Progress and Promise in Treatment Personalization for Advanced Prostate Cancer - Lighting the Way: Lutetium in the Treatment Paradigm February 17, 2021

ASCO GU 2021: Bench to Bedside: Critical Pathways in Renal Cell Carcinoma – Cure the Cancer or Avoid Dialysis? Helping Decide February 17, 2021

ASCO GU 2021: An Exploratory Gene-by-Gene Analysis of Patients with mCRPC Treated with Olaparib in the PROfound Trial February 17, 2021

ASCO GU 2021: A Phase III Study of Apalutamide vs Placebo In Patients with mCSPC Receiving ADT: Final Analysis Results From TITAN February 17, 2021

ASCO GU 2021: Genomic Landscape of Advanced Prostate Cancer in Racial Minority Populations February 17, 2021

ASCO GU 2021: Enfortumab Vedotin In Cisplatin-Ineligible Patients with Locally Advanced Or Metastatic Urothelial Cancer Who Received Prior PD-1/PD-L1 Inhibitors: EV-201 Cohort 2 February 17, 2021

ASCO GU 2021: Primary results of EV-301: A Phase III Trial of Enfortumab Vedotin vs Chemotherapy in Patients With Previously Treated Locally Advanced or Metastatic Urothelial Carcinoma February 17, 2021

ASCO GU 2021: Radical Cystectomy for High-Risk Non-Muscle-Invasive Bladder Cancer: Who and Why? February 17, 2021

ASCO GU 2021: SGNTUC-019: Phase II Basket Study of Tucatinib and Trastuzumab in Previously Treated Solid Tumors with HER2 Alterations: Urothelial Cancer Cohort February 17, 2021

ASCO GU 2021: Comprehensive Genomic Profiling in Patients with Relapsed/Refractory Germ Cell Tumors February 16, 2021

ASCO GU 2021: Pre-Orchiectomy Serum Tumor Markers as a Predictor of Recurrence in Stage I Germ Cell Tumors February 16, 2021

ASCO GU 2021: Bench to Bedside: Critical Pathways in Renal Cell Carcinoma – Peri-Operative Morbidity and Mortality in a Modern Series of Patients Treated with Cytoreductive Nephrectomy at Five Centers February 16, 2021

ASCO GU 2021: Paclitaxel, Ifosfamide & Cisplatin (TIP) as Second-Line Therapy for Germ Cell Tumors: Long-Term Follow-up and Expansion Cohort February 16, 2021

ASCO GU 2021: Deintensification of Management of Low-Risk Non-Muscle-Invasive Bladder Cancer February 16, 2021

ASCO GU 2021: Socio-Environmental Conditions Associated with Geospatial Clusters of Urothelial Carcinoma: A Multi-Institutional Analysis February 16, 2021

ASCO GU 2021: Tailored Immunotherapy Approach with Nivolumab in Advanced Transitional Cell Carcinoma (TITAN-TCC) February 16, 2021

ASCO GU 2021: Surgery In Early Metastatic Seminoma, The Phase II SEMS Trial February 16, 2021

Page 6 of 392